Featured Technology

Success Stories

Copaxone - as marketed by Teva Pharmaceuticals
The first innovative drug to be developed in Israel and to receive FDA approval, Copaxone® is a unique multiple sclerosis immunomodulator: the first and only non-interferon agent for the treatment of relapsing-remitting multiple sclerosis. Copaxone® is...